Details for: LIFR
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 34.45rCSI 47.14%PRS 57.67
-
CSI 24.64rCSI 75.93%PRS 72.43
-
CSI 24.56rCSI 55.06%PRS 46.67
-
CSI 22.07rCSI 47.02%PRS 36.36
-
CSI 20.27rCSI 25.07%PRS 61.26
-
CSI 20.17rCSI 51.85%PRS 63.54
-
CSI 17.86rCSI 45.18%PRS 72.28
-
CSI 16.82rCSI 26.85%PRS 68.78
-
CSI 16.65rCSI 13.16%PRS 51.39
-
CSI 14.52rCSI 30.14%PRS 61.68
-
CSI 12.42rCSI 18.2%PRS 80.35
-
CSI 11.02rCSI 15%PRS 75.84
-
CSI 10.54rCSI 14.94%PRS 60.91
-
CSI 10.19rCSI 9.81%PRS 64.45
-
CSI 10.05rCSI 20.39%PRS 43.51
-
CSI 9.56rCSI 11.64%PRS 72.03
-
CSI 9.35rCSI 25.53%PRS 80.9
-
CSI 8.87rCSI 51.13%PRS 62.93
-
CSI 8.84rCSI 43.57%PRS 75.35
-
CSI 8.84rCSI 11.82%PRS 73.4
-
CSI 8.69rCSI 15.23%PRS 56.54
-
CSI 8.63rCSI 15.21%PRS 61.11
-
CSI 8.31rCSI 13.94%PRS 45.98
-
CSI 8.12rCSI 32.74%PRS 63.45
-
CSI 8.11rCSI 16.66%PRS 54.37
-
CSI 8.02rCSI 44.48%PRS 79.18
-
CSI 7.7rCSI 52.86%PRS 76.66
-
CSI 7.41rCSI 16.92%PRS 56.13
-
CSI 7.29rCSI 20.73%PRS 62.45
-
CSI 7.28rCSI 11.62%PRS 56.88
-
CSI 7.07rCSI 12.95%PRS 74.8
-
CSI 7.05rCSI 20.3%PRS 77.11
-
CSI 6.77rCSI 24.37%PRS 44.29
-
CSI 6.73rCSI 8.37%PRS 44.16
-
CSI 6.71rCSI 22.48%PRS 49.38
-
CSI 6.7rCSI 15.47%PRS 53.19
-
CSI 6.65rCSI 9.09%PRS 70.41
-
CSI 6.54rCSI 12.46%PRS 78.85
-
CSI 6.53rCSI 29.54%PRS 79.87
-
CSI 6.5rCSI 15.8%PRS 44.46
-
CSI 6.5rCSI 6.78%PRS 64.88
-
CSI 6.19rCSI 43.77%PRS 56.45
-
CSI 6.03rCSI 10.43%PRS 54.63
-
CSI 5.92rCSI 14.45%PRS 57.69
-
CSI 5.83rCSI 6.39%PRS 68.24
-
CSI 5.79rCSI 10.22%PRS 45.07
-
CSI 5.72rCSI 7.35%PRS 56.83
-
CSI 5.67rCSI 5.27%PRS 65.2
-
CSI 5.64rCSI 14.33%PRS 58.62
-
CSI 5.62rCSI 21.06%PRS 56.46
-
CSI 5.19rCSI 13.54%PRS 64.28
-
CSI 5.04rCSI 15.77%PRS 50.07
-
CSI 4.85rCSI 11.65%PRS 71.72
-
CSI 4.76rCSI 14.89%PRS 47.63
-
CSI 4.73rCSI 10.41%PRS 47.22
-
CSI 4.65rCSI 18.93%PRS 58.28
-
CSI 4.64rCSI 15.04%PRS 64.39
-
CSI 4.61rCSI 4.05%PRS 52.46
-
CSI 4.54rCSI 3.36%PRS 57.08
-
CSI 4.35rCSI 3.75%PRS 69.46
-
CSI 4.3rCSI 5.54%PRS 47.26
-
CSI 4.19rCSI 15.84%PRS 46.66
-
CSI 4.17rCSI 6.83%PRS 53.64
-
CSI 4.13rCSI 12.2%PRS 54.39
-
CSI 4.1rCSI 9.37%PRS 64.56
-
CSI 4.06rCSI 11.77%PRS 54.04
-
CSI 3.62rCSI 32.09%PRS 79.75
-
CSI 3.57rCSI 6.49%PRS 56.24
-
CSI 3.57rCSI 10.59%PRS 74.22
-
CSI 3.41rCSI 5.2%PRS 65.27
-
CSI 3.39rCSI 5.24%PRS 63.01
-
CSI 3.34rCSI 14.2%PRS 57.63
-
CSI 3.24rCSI 7.15%PRS 50.52
-
CSI 3.21rCSI 10.28%PRS 61.63
-
CSI 3.18rCSI 2.64%PRS 64
-
CSI 3.18rCSI 4.25%PRS 64.79
-
CSI 3.17rCSI 15.18%PRS 64.52
-
CSI 3.14rCSI 3.14%PRS 57.95
-
CSI 3.13rCSI 8.08%PRS 59.53
-
CSI 3.04rCSI 22.22%PRS 79.91
-
CSI 3.02rCSI 4.33%PRS 54.12
-
CSI 2.94rCSI 2.39%PRS 64.88
-
CSI 2.91rCSI 15.67%PRS 75.95
-
CSI 2.86rCSI 8.04%PRS 61.02
-
CSI 2.85rCSI 5.38%PRS 81.89
-
CSI 2.84rCSI 20.3%PRS 64.43
-
CSI 2.83rCSI 2.19%PRS 66.99
-
CSI 2.83rCSI 4.15%PRS 57.81
-
CSI 2.74rCSI 55.73%PRS 56.58
-
CSI 2.71rCSI 6.32%PRS 81.51
-
CSI 2.7rCSI 4.18%PRS 71.64
-
CSI 2.68rCSI 12.82%PRS 62.75
-
CSI 2.63rCSI 6.84%PRS 67.91
-
CSI 2.62rCSI 8.42%PRS 62.41
-
CSI 2.56rCSI 20.42%PRS 81.32
-
CSI 2.55rCSI 4.03%PRS 67.05
-
CSI 2.53rCSI 6.04%PRS 65.13
-
CSI 2.53rCSI 3.02%PRS 45.79
-
CSI 2.51rCSI 5.04%PRS 53.53
-
CSI 2.49rCSI 8.54%PRS 53.06
-
CSI 0.2rCSI 1.9%PRS 81.7%
-
CSI 0.5rCSI 5.1%PRS 76.0%
-
CSI 0.5rCSI 6.8%PRS 55.5%
-
CSI 0.6rCSI 1.4%PRS 51.6%
-
CSI 0.7rCSI 3.8%PRS 77.7%
-
CSI 0.7rCSI 4.5%PRS 56.3%
-
CSI 0.8rCSI 7.0%PRS 87.6%
-
CSI 0.8rCSI 3.2%PRS 78.4%
-
CSI 0.9rCSI 6.5%PRS 51.0%
-
CSI 0.9rCSI 4.0%PRS 64.4%
-
CSI 1.0rCSI 10.1%PRS 62.6%
-
CSI 1.1rCSI 6.8%PRS 73.6%
-
CSI 1.1rCSI 4.5%PRS 76.3%
-
CSI 1.1rCSI 8.5%PRS 70.3%
-
CSI 1.3rCSI 1.8%PRS 70.9%
-
CSI 1.3rCSI 11.4%PRS 51.6%
-
CSI 1.4rCSI 7.6%PRS 73.0%
-
CSI 1.5rCSI 8.9%PRS 47.1%
-
CSI 1.5rCSI 4.2%PRS 76.6%
-
CSI 1.6rCSI 31.7%PRS 55.1%
-
CSI 1.6rCSI 13.7%PRS 61.2%
-
CSI 1.6rCSI 5.2%PRS 69.2%
-
CSI 1.6rCSI 39.5%PRS 45.8%
-
CSI 1.7rCSI 6.1%PRS 72.5%
-
CSI 1.8rCSI 2.0%PRS 54.9%
-
CSI 1.8rCSI 3.2%PRS 63.7%
-
CSI 1.8rCSI 4.3%PRS 72.7%
-
CSI 1.9rCSI 46.3%PRS 45.0%
-
CSI 2.0rCSI 2.5%PRS 69.3%
-
CSI 2.0rCSI 2.5%PRS 62.7%
-
CSI 2.1rCSI 5.6%PRS 55.5%
-
CSI 2.1rCSI 5.2%PRS 63.1%
-
CSI 2.1rCSI 2.1%PRS 55.4%
-
CSI 2.2rCSI 11.9%PRS 62.7%
-
CSI 2.2rCSI 3.6%PRS 47.9%
-
CSI 2.2rCSI 43.3%PRS 78.9%
-
CSI 2.3rCSI 5.7%PRS 53.9%
-
CSI 2.3rCSI 3.3%PRS 74.9%
-
CSI 2.3rCSI 3.7%PRS 57.0%
-
CSI 2.4rCSI 11.0%PRS 74.9%
-
CSI 2.4rCSI 6.7%PRS 59.9%
-
CSI 2.5rCSI 8.5%PRS 53.1%
-
CSI 2.5rCSI 5.0%PRS 53.5%
-
CSI 2.5rCSI 3.0%PRS 45.8%
-
CSI 2.5rCSI 6.0%PRS 65.1%
-
CSI 2.6rCSI 4.0%PRS 67.1%
-
CSI 2.6rCSI 20.4%PRS 81.3%
-
CSI 2.6rCSI 8.4%PRS 62.4%
-
CSI 2.6rCSI 6.8%PRS 67.9%
-
CSI 2.7rCSI 12.8%PRS 62.8%
-
CSI 2.7rCSI 4.2%PRS 71.6%
-
CSI 2.7rCSI 6.3%PRS 81.5%
-
CSI 2.7rCSI 55.7%PRS 56.6%
-
CSI 2.8rCSI 4.2%PRS 57.8%
-
CSI 2.8rCSI 2.2%PRS 67.0%
-
CSI 2.8rCSI 20.3%PRS 64.4%
-
CSI 2.9rCSI 5.4%PRS 81.9%
-
CSI 2.9rCSI 8.0%PRS 61.0%
-
CSI 2.9rCSI 15.7%PRS 76.0%
-
CSI 2.9rCSI 2.4%PRS 64.9%
-
CSI 3.0rCSI 4.3%PRS 54.1%
-
CSI 3.0rCSI 22.2%PRS 79.9%
-
CSI 3.1rCSI 8.1%PRS 59.5%
-
CSI 3.1rCSI 3.1%PRS 58.0%
-
CSI 3.2rCSI 15.2%PRS 64.5%
-
CSI 3.2rCSI 4.3%PRS 64.8%
-
CSI 3.2rCSI 2.6%PRS 64.0%
-
CSI 3.2rCSI 10.3%PRS 61.6%
-
CSI 3.2rCSI 7.2%PRS 50.5%
-
CSI 3.3rCSI 14.2%PRS 57.6%
-
CSI 3.4rCSI 5.2%PRS 63.0%
-
CSI 3.4rCSI 5.2%PRS 65.3%
-
CSI 3.6rCSI 10.6%PRS 74.2%
-
CSI 3.6rCSI 6.5%PRS 56.2%
-
CSI 3.6rCSI 32.1%PRS 79.8%
-
CSI 4.1rCSI 11.8%PRS 54.0%
-
CSI 4.1rCSI 9.4%PRS 64.6%
-
CSI 4.1rCSI 12.2%PRS 54.4%
-
CSI 4.2rCSI 6.8%PRS 53.6%
-
CSI 4.2rCSI 15.8%PRS 46.7%
-
CSI 4.3rCSI 5.5%PRS 47.3%
-
CSI 4.4rCSI 3.8%PRS 69.5%
-
CSI 4.5rCSI 3.4%PRS 57.1%
-
CSI 4.6rCSI 4.1%PRS 52.5%
-
CSI 4.6rCSI 15.0%PRS 64.4%
-
CSI 4.7rCSI 18.9%PRS 58.3%
-
CSI 4.7rCSI 10.4%PRS 47.2%
-
CSI 4.8rCSI 14.9%PRS 47.6%
-
CSI 4.9rCSI 11.7%PRS 71.7%
-
CSI 5.0rCSI 15.8%PRS 50.1%
-
CSI 5.2rCSI 13.5%PRS 64.3%
-
CSI 5.6rCSI 21.1%PRS 56.5%
-
CSI 5.6rCSI 14.3%PRS 58.6%
-
CSI 5.7rCSI 5.3%PRS 65.2%
-
CSI 5.7rCSI 7.4%PRS 56.8%
-
CSI 5.8rCSI 10.2%PRS 45.1%
-
CSI 5.8rCSI 6.4%PRS 68.2%
-
CSI 5.9rCSI 14.5%PRS 57.7%
-
CSI 6.0rCSI 10.4%PRS 54.6%
-
CSI 6.2rCSI 43.8%PRS 56.5%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 3201650940
Symbol: LIFR_HUMAN
Name: Leukemia inhibitory factor receptor
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 1915266
Title: Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130.
PubMed ID: 1915266
PubMed ID: 9525740
Title: The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in upregulation of PLAG1 gene expression under control of the LIFR promoter.
PubMed ID: 9525740
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 18775332
Title: Structural organization of a full-length gp130/LIF-R cytokine receptor transmembrane complex.
PubMed ID: 18775332
PubMed ID: 14740318
Title: Null leukemia inhibitory factor receptor (LIFR) mutations in Stueve-Wiedemann/Schwartz-Jampel type 2 syndrome.
PubMed ID: 14740318
DOI: 10.1086/381715
PubMed ID: 16959974
Title: The consensus coding sequences of human breast and colorectal cancers.
PubMed ID: 16959974
Sequence Information:
- Length: 1097
- Mass: 123743
- Checksum: C8602897E359FCE5
- Sequence:
MMDIYVCLKR PSWMVDNKRM RTASNFQWLL STFILLYLMN QVNSQKKGAP HDLKCVTNNL QVWNCSWKAP SGTGRGTDYE VCIENRSRSC YQLEKTSIKI PALSHGDYEI TINSLHDFGS STSKFTLNEQ NVSLIPDTPE ILNLSADFST STLYLKWNDR GSVFPHRSNV IWEIKVLRKE SMELVKLVTH NTTLNGKDTL HHWSWASDMP LECAIHFVEI RCYIDNLHFS GLEEWSDWSP VKNISWIPDS QTKVFPQDKV ILVGSDITFC CVSQEKVLSA LIGHTNCPLI HLDGENVAIK IRNISVSASS GTNVVFTTED NIFGTVIFAG YPPDTPQQLN CETHDLKEII CSWNPGRVTA LVGPRATSYT LVESFSGKYV RLKRAEAPTN ESYQLLFQML PNQEIYNFTL NAHNPLGRSQ STILVNITEK VYPHTPTSFK VKDINSTAVK LSWHLPGNFA KINFLCEIEI KKSNSVQEQR NVTIKGVENS SYLVALDKLN PYTLYTFRIR CSTETFWKWS KWSNKKQHLT TEASPSKGPD TWREWSSDGK NLIIYWKPLP INEANGKILS YNVSCSSDEE TQSLSEIPDP QHKAEIRLDK NDYIISVVAK NSVGSSPPSK IASMEIPNDD LKIEQVVGMG KGILLTWHYD PNMTCDYVIK WCNSSRSEPC LMDWRKVPSN STETVIESDE FRPGIRYNFF LYGCRNQGYQ LLRSMIGYIE ELAPIVAPNF TVEDTSADSI LVKWEDIPVE ELRGFLRGYL FYFGKGERDT SKMRVLESGR SDIKVKNITD ISQKTLRIAD LQGKTSYHLV LRAYTDGGVG PEKSMYVVTK ENSVGLIIAI LIPVAVAVIV GVVTSILCYR KREWIKETFY PDIPNPENCK ALQFQKSVCE GSSALKTLEM NPCTPNNVEV LETRSAFPKI EDTEIISPVA ERPEDRSDAE PENHVVVSYC PPIIEEEIPN PAADEAGGTA QVIYIDVQSM YQPQAKPEEE QENDPVGGAG YKPQMHLPIN STVEDIAAEE DLDKTAGYRP QANVNTWNLV SPDSPRSIDS NSEIVSFGSP CSINSRQFLI PPKDEDSPKS NGGGWSFTNF FQNKPND
Genular Protein ID: 3966010311
Symbol: A8K1Z4_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Sequence Information:
- Length: 1097
- Mass: 123831
- Checksum: 5E600CB2EE929FF6
- Sequence:
MMDIYVCLKR PSWMVDNKRM RTASNFQWLL STFILLYLMN QVNSQKKGAP HDLKCVTNNL QVWNCSWKAP SGTGRGTDYE VCIENRSRSC YQLEKTSIKI PALSHGDYEI TINSLHDFGS STSKFTLNEQ NVSLIPDTPE ILNLSADFST STLYLKWNDR GSVFPHRSNV IWEIKVLRKE SMELVKLVTH NTTLNGKDTL HHWSWASDMP LECAIHFVEI RCYIDNLHFS GLEEWSDWSP VRNISWIPDS QTKVFPQDKV ILVGSDITFC CVSQEKVLSA LIGHTNCPLI HLDGENVAIK IRNISVSASS GTNVVFTTED NIFGTVIFAG YPPDTPQQLN CETHDLKEII CSWNPGRVTA LVGPRATSYT LVESFSGKYV RLKRAEAPTN ESYQLLFQML PNQEIYNFTL NAHNPLGRSQ STILVNITEK VYPHTPTSFK VKDINSTAVK LSWHLPGNFA KINFLCEIEI KKSNSVQEQR NVTIKGVENS SYLVALDKLN PYTLYTFRIR CSTETFWKWS KWSNKKQHLT TEASPSKGPD TWREWSSDGK NLIIYWKPLP INEANGKILS YNVSCSSDEE TQSLSEIPDP QHKAEIRLDK NDYIISVVAK NSVGSSPPSK IASMEIPNDD LKIEQVVGMG KGILLTWHYD PNMTCDYVIK WCNSSRSEPC LMDWRKVPSN STETVIESDE FRPGIRYNFF LYGCRNQGYQ LLRSMIGYIE ELAPIVAPNF TVEDTSADSI LVKWEDIPVE ELRGFLRGYL FYFGKGERDT SKMRVLESGR SDIKVKNITD ISQKTLRIAD LQGKTSYHLV LRAYTDGGVG PEKSMYVVTK ENSVGLIIAI LIPVAVAVIV GVVTSILCYR KREWIKETFY PDIPNPENCK ALQFQKSVCE GSSALKTLEM NPCTPNNVEV LETRSAFPKI EDTEIISPVA ERPEDRSDAE PENHVVVSYC PPIIEEEIPN PAADEAGGTA QVIYIDVQSM YQPQAKPEEE QENDPVGGAG YKPQMHLPIN STVEDIAAEE DLDKTAGYRP QANVNTWNLV SPDSPRSIDS NSEIVSFGSP CSINSRQFLI PPKDEDFPKS NGGGWSFTNF FQNKPND